DOSSIERS / DALKEN PHARMA CONSULTING
← SearchExport PDF
Company dossier

DALKEN PHARMA CONSULTING

FRANCE · COMPANY · INCORPORATED 2020-03-17
KYBE ID: FR-882536162 · 882536162 · 1 sources
RISK SCORE12LOW RISK
OverviewOwnershipPeopleRisk signals 1Sources

Key facts

active
DALKEN PHARMA CONSULTING
fr_insee
882536162
fr_insee
active
fr_insee
Limited liability company (SARL)
fr_insee
2020-03-17
fr_insee
56 RUE de Sèvres, 92100 Boulogne-Billancourt
fr_insee
70.22Z
fr_insee
€1,000
fr_insee

Ownership structure

1 entities

No ownership links on record for this entity.

Companies at this address

58 total

⚠ Mass-registration address — typical of formation agents; review for shell risk.

AGEAdissolvedAIL SARLdissolvedALEXANDRA MARIE BRIGITTE HUBERLANDactiveARMAN FARHATactiveASIA MINUTEdissolvedASSOCIATION DES PHARMACIENS DE BOULOGNE BILLANCOURTactiveCARRASSET CONSEILdissolvedCHARLOTTE MARINE JEANNE LABARTHETTEactiveCLEMENCE MARIE FLORENCE DE BESOMBESactiveCORHUMdissolvedDELICESactiveDUMONTEAMdissolvedELISABETH CARTactiveFRANCE DIFFUSION MEDICALEdissolvedFRANCOIS BAZINdissolvedGIANNI LUCIEN SARTENAactiveGRAPHICANAdissolvedHKactiveINES JAISdissolvedINTERNATIONAL CONNEXIONdissolved

+38 more

People with significant control

1 people
NameRoleFromSource
DALILA BOUDRAAPrésident—France registry

Risk signals

1 matched
medium

Shared registered address

Address shared by 58 companies

Risk journey — why 12?

1 signals
+12
Shared registered address
Composite risk score12/100